Abstract
BACKGROUND: Osteoarthritis (OA) is a major cause of disability, which will increase further with longer lifetime and higher average weight of the population. OBJECTIVE: To review a hierarchy of interventions for OA in clinical practice, and compare it with the Strength of Recommendation (SOR) proposed by the Osteoarthritis Research Society International (OARSI). METHODS: Search for relevant randomized controlled trials in databases, as well as published systematic reviews and meta-analyses. RESULTS/CONCLUSIONS: Preventive measures are few and uncertain; however, basic therapy includes reduction in weight in the obese and exercises to keep in shape; this is in accordance with the OARSI guidelines (OARSI, 100% consensus) emphasizing the need for obese individuals with knee OA to lose weight (OARSI, SOR = 96%). There are indications of an effect of some nutraceuticals, though further studies are needed for validation (OARSI, SOR = 63%). Pharmacological treatment has paracetamol as primary prescription, which is a safe, albeit weak analgesic. Supplementary medications are prescribed according to level of pain and possible inflammation.
Original language | English |
---|---|
Journal | Expert Opinion on Pharmacotherapy |
Volume | 10 |
Issue number | 11 |
Pages (from-to) | 1793-804 |
Number of pages | 12 |
ISSN | 1465-6566 |
DOIs | |
Publication status | Published - 2009 |
Fingerprint
Dive into the research topics of 'The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making'. Together they form a unique fingerprint.Cite this
Bliddal, H., & Christensen, R. (2009). The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making. Expert Opinion on Pharmacotherapy, 10(11), 1793-804. https://doi.org/10.1517/14656560903018911